当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析 - 现金流量表

迪哲医药-U

(688192)

  

流通市值:296.77亿  总市值:332.75亿
流通股本:4.10亿   总股本:4.59亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金346,296,077.75164,190,860.93436,632,069.94351,202,757
  收到其他与经营活动有关的现金35,726,130.6725,289,636.2448,468,571.5136,765,185.27
  经营活动现金流入小计382,022,208.42189,480,497.17485,100,641.45387,967,942.27
  购买商品、接受劳务支付的现金216,360,655.34112,191,453440,106,399.09314,101,865.37
  支付给职工以及为职工支付的现金288,977,995.47158,493,226.49478,161,922.79360,375,145.45
  支付的各项税费4,727,195.752,481,587.6620,704,986.426,545,893.85
  支付其他与经营活动有关的现金136,625,730.647,981,189.48196,652,797.42170,253,378.02
  经营活动现金流出小计646,691,577.16321,147,456.631,135,626,105.72851,276,282.69
  经营活动产生的现金流量净额-264,669,368.74-131,666,959.46-650,525,464.27-463,308,340.42
二、投资活动产生的现金流量:
  收回投资收到的现金3,631,596,974.15732,182,713.484,018,911,576.932,709,870,267.04
  处置固定资产、无形资产和其他长期资产收回的现金净额7,607.2---
  投资活动现金流入小计3,631,604,581.35732,182,713.484,018,911,576.932,709,870,267.04
  购建固定资产、无形资产和其他长期资产支付的现金112,832,364.7675,832,800.06137,575,882.8594,076,925.33
  投资支付的现金4,036,000,000785,000,0003,919,410,0002,702,410,000
  投资活动现金流出小计4,148,832,364.76860,832,800.064,056,985,882.852,796,486,925.33
  投资活动产生的现金流量净额-517,227,783.41-128,650,086.58-38,074,305.92-86,616,658.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,776,367,935.51-100,000,000100,000,000
  其中:子公司吸收少数股东投资收到的现金---100,000,000
  取得借款收到的现金557,217,810.54391,343,495.54963,356,991.23703,475,604.85
  收到其他与筹资活动有关的现金--58,266,328.2639,094,705
  筹资活动现金流入小计2,333,585,746.05391,343,495.541,121,623,319.49842,570,309.85
  偿还债务支付的现金524,177,885.12112,665,800203,726,151.95201,626,921.95
  分配股利、利润或偿付利息支付的现金18,961,195.249,055,170.7720,553,670.3612,755,239.44
  支付其他与筹资活动有关的现金14,071,001.347,005,473.730,330,708.0421,384,908.05
  筹资活动现金流出小计557,210,081.7128,726,444.47254,610,530.35235,767,069.44
  筹资活动产生的现金流量净额1,776,375,664.35262,617,051.07867,012,789.14606,803,240.41
四、汇率变动对现金及现金等价物的影响-77,388.6341,823.67-2,449,850.28-247,852.6
五、现金及现金等价物净增加额994,401,123.572,341,828.7175,963,168.6756,630,389.1
  加:期初现金及现金等价物余额249,889,742.63249,889,742.6373,926,573.9673,926,573.96
  期末现金及现金等价物余额1,244,290,866.2252,231,571.33249,889,742.63130,556,963.06
补充资料:
  净利润-379,042,400.14--939,655,188.7-
  固定资产和投资性房地产折旧3,996,203.15-8,069,923.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,996,203.15-8,069,923.78-
  无形资产摊销16,792,781.84-33,663,118.86-
  长期待摊费用摊销4,111,508.65-10,653,489.06-
  递延收益摊销-717,522.73---
  处置固定资产、无形资产和其他长期资产的损失-279.52---
  公允价值变动损失-11,219,000.56--14,450,692.6-
  财务费用17,229,479.65-25,204,374.51-
  存货的减少3,567,558.94--20,644,075.82-
  经营性应收项目的减少-16,212,458.58-23,699,487.15-
  经营性应付项目的增加49,664,403.84-65,601,150.2-
  其他34,316,897.32-132,818,342.27-
  现金的期末余额1,244,290,866.2-249,889,742.63-
  减:现金的期初余额249,889,742.63-73,926,573.96-
  现金及现金等价物的净增加额994,401,123.57-175,963,168.67-
公告日期2025-08-232025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑